Press Release April 24, 2023 Diabetic Retinopathy Pipeline Report builds Understanding of the Limitations and Challenges with Regard to the Development | Major Companies – Novartis, Bayer, and Others
Press Release April 24, 2023 Chronic Obstructive Pulmonary Disease Pipeline Assets and Comparative Analysis of Clinical and Non-Clinical Stage Products | Major Companies – Sanofi, AstraZeneca, Pfizer, and Others
Press Release April 24, 2023 Chronic Hepatitis B Virus Pipeline Assets and Comparative Analysis of Clinical and Non-Clinical Stage Products | Major Companies- Vedanta Biosciences, Janssen Pharma, and Others
Press Release April 24, 2023 Cholangiocarcinoma Pipeline Assets Segmented By Stage, Product Type, Route of Administration and Molecule | Major Companies – Merck Sharp & Dohme Corp., Eisai Inc, and Others
Press Release April 24, 2023 Chronic Lymphocytic Leukemia Pipeline Report Provides the Assessment of Mono and Combination Therapies by Stage | Major Companies – Loxo Oncology, Oncternal Therapeutics, and Others
Press Release April 24, 2023 Advanced Ovarian Cancer Pipeline Report builds understanding of the Limitations and challenges with regard to the development of Advanced Ovarian Cancer | Major Companies – AstraZeneca, Pfizer, Merck,
Press Release April 24, 2023 Advanced Gastric Carcinoma Pipeline Assets and Comparative Analysis of Clinical and Non-Clinical Stage Products | Major Companies – Bristol-Myers Squibb, AstraZeneca, Genentech, and Others
Press Release April 24, 2023 Wet Age-Related Macular Degeneration Pipeline Assets Segmented By Stage, Product Type, Route of Administration and Molecule | Major Companies – Sandoz, Roche, and Others
Press Release April 24, 2023 Neuropathic Ocular Pain Market to Observe Impressive Growth During the Forecast Period (2022-2032), Evaluates DelveInsight | Key Companies – Novartis, OKYO Pharma, AbbVie Inc., Aciex, Novartis
Press Release April 24, 2023 WHIM Syndrome Market to Exhibit Moderate Growth Rate During the Forecast Period (2022-2032), Investigates DelveInsight | Key Companies – X4 Pharmaceuticals, NIAID, GSK plc, Bristol Myers Squibb